Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 8
2004 2
2005 5
2006 5
2007 9
2008 11
2009 9
2010 18
2011 17
2012 17
2013 26
2014 34
2015 34
2016 29
2017 34
2018 36
2019 53
2020 53
2021 60
2022 67
2023 52
2024 26

Text availability

Article attribute

Article type

Publication date

Search Results

555 results

Results by year

Filters applied: . Clear all
Page 1
PD-L1/TLR7 dual-targeting nanobody-drug conjugate mediates potent tumor regression via elevating tumor immunogenicity in a host-expressed PD-L1 bias-dependent way.
Yu X, Long Y, Chen B, Tong Y, Shan M, Jia X, Hu C, Liu M, Zhou J, Tang F, Lu H, Chen R, Xu P, Huang W, Ren J, Wan Y, Sun J, Li J, Jin G, Gong L. Yu X, et al. Among authors: zhou j. J Immunother Cancer. 2022 Oct;10(10):e004590. doi: 10.1136/jitc-2022-004590. J Immunother Cancer. 2022. PMID: 36253000 Free PMC article.
Genomic innovation for crop improvement.
Bevan MW, Uauy C, Wulff BB, Zhou J, Krasileva K, Clark MD. Bevan MW, et al. Among authors: zhou j. Nature. 2017 Mar 15;543(7645):346-354. doi: 10.1038/nature22011. Nature. 2017. PMID: 28300107 Free article. Review.
Newborns' voice: We need pain management!
Chen H, da Palma Afonso E, Zhou J. Chen H, et al. Among authors: zhou j. Intensive Crit Care Nurs. 2021 Feb;62:102976. doi: 10.1016/j.iccn.2020.102976. Epub 2020 Nov 27. Intensive Crit Care Nurs. 2021. PMID: 33257216 No abstract available.
Efficacy, Safety, Patient Experience, and Tolerability of Risankizumab Administered by On-Body Injector for Moderate to Severe Crohn's Disease.
Loftus EV Jr, Griffith J, Neimark E, Song A, Wallace K, Nannapaneni S, Zhou J, Byrne R, Kligys K, Pang Y, Liao X, Kalabic J, Dubinsky M. Loftus EV Jr, et al. Among authors: zhou j. Adv Ther. 2023 May;40(5):2311-2325. doi: 10.1007/s12325-023-02477-2. Epub 2023 Mar 14. Adv Ther. 2023. PMID: 36917429 Free PMC article. Clinical Trial.
Histidine-rich glycoprotein attenuates catheter thrombosis.
Malik RA, Liao P, Zhou J, Hussain R, Fredenburgh JC, Hettrick L, Revenko AS, Weitz JI. Malik RA, et al. Among authors: zhou j. Blood Adv. 2023 Sep 26;7(18):5651-5660. doi: 10.1182/bloodadvances.2022009236. Blood Adv. 2023. PMID: 37042966 Free PMC article.
555 results